Skip to main content
Log in

FDA warns of asenapine hypersensitivity

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. FDA.FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate). Internet Document: [2 pages], 30 Aug 2011. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FDA warns of asenapine hypersensitivity. React. Wkly. 1368, 2 (2011). https://doi.org/10.2165/00128415-201113680-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113680-00004

Keywords

Navigation